Literature DB >> 10983899

Cognitive outcome in acute sporadic encephalitis.

L Hokkanen1, J Launes.   

Abstract

Acute encephalitis is an inflammation of the brain parenchyma. In the United States, 20,000 cases occur yearly. A variety of cognitive deficits, often the sole cause of disability, may persist after the acute stage. Still, infectious diseases tend to be covered only briefly in neuropsychological handbooks. Recent literature demonstrates the heterogeneity of both amnestic disorders and the outcome following encephalitides. Herpes Simplex virus (HSV), the most common single etiology of sporadic encephalitis, usually causes the most severe symptoms. Modern antiviral medication, however, seems to improve the cognitive outcome. Much less is known about non-HSV encephalitides, where both mild and severe defects have been observed. This article summarizes the current knowledge and also calls upon a more active neuropsychological research in the area.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10983899     DOI: 10.1023/a:1009079531196

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   6.940


  174 in total

1.  Selective loss of imagery in a case of visual agnosia.

Authors:  Z Mehta; F Newcombe; E De Haan
Journal:  Neuropsychologia       Date:  1992-07       Impact factor: 3.139

2.  Focal retrograde amnesia following bilateral temporal lobe pathology. A neuropsychological and magnetic resonance study.

Authors:  N Kapur; D Ellison; M P Smith; D L McLellan; E H Burrows
Journal:  Brain       Date:  1992-02       Impact factor: 13.501

Review 3.  The medial temporal lobe memory system.

Authors:  L R Squire; S Zola-Morgan
Journal:  Science       Date:  1991-09-20       Impact factor: 47.728

4.  Severe encephalitis with rapid recovery.

Authors:  C Y Tong; F A Potter; K A Pang; J Vora
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

5.  The limbic system and the localisation of herpes simplex encephalitis.

Authors:  A R Damasio; G W Van Hoesen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

6.  Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases.

Authors:  M N Hart; K M Earle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-06       Impact factor: 10.154

7.  Neuropsychological deficits in Lyme disease patients with and without other evidence of central nervous system pathology.

Authors:  R F Kaplan; L Jones-Woodward; K Workman; A C Steere; E L Logigian; M E Meadows
Journal:  Appl Neuropsychol       Date:  1999

8.  The fractionation of retrograde amnesia.

Authors:  E K Warrington; R A McCarthy
Journal:  Brain Cogn       Date:  1988-04       Impact factor: 2.310

9.  The implicit memory ability of a patient with amnesia due to encephalitis.

Authors:  L S Cermak; S P Blackford; M O'Connor; R P Bleich
Journal:  Brain Cogn       Date:  1988-04       Impact factor: 2.310

10.  Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

Authors:  B Sköldenberg; M Forsgren; K Alestig; T Bergström; L Burman; E Dahlqvist; A Forkman; A Frydén; K Lövgren; K Norlin
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

View more
  7 in total

1.  Antiviral agents in Alzheimer's disease: hope for the future?

Authors:  Matthew A Wozniak; Ruth F Itzhaki
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

2.  Dementia following herpes zoster encephalitis.

Authors:  Katherine J Bangen; Lisa Delano-Wood; Christina E Wierenga; Nikki H Stricker; John R Hesselink; Mark W Bondi
Journal:  Clin Neuropsychol       Date:  2010-05-24       Impact factor: 3.535

Review 3.  Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia.

Authors:  Konasale M Prasad; Annie M M Watson; Faith B Dickerson; Robert H Yolken; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2012-04-06       Impact factor: 9.306

Review 4.  Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease.

Authors:  D P Devanand
Journal:  Curr Neurol Neurosci Rep       Date:  2018-07-14       Impact factor: 5.081

5.  Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial.

Authors:  D P Devanand; Howard Andrews; William C Kreisl; Qolamreza Razlighi; Anne Gershon; Yaakov Stern; Akiva Mintz; Thomas Wisniewski; Edward Acosta; Julianna Pollina; Mariasofia Katsikoumbas; Karen L Bell; Gregory H Pelton; Deborah Deliyannides; K M Prasad; Edward D Huey
Journal:  BMJ Open       Date:  2020-02-06       Impact factor: 2.692

6.  Postencephalitic amnesia with long term-working memory impairment: A case report.

Authors:  Beatriz Baldivia; Pablo Resende Saa; Maria Sheila Guimarães Rocha; Sonia Maria Dozzi Brucki
Journal:  Dement Neuropsychol       Date:  2008 Oct-Dec

Review 7.  Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.

Authors:  Rodolfo Furlan Damiano; Bruno F Guedes; Cristiana Castanho de Rocca; Antonio de Pádua Serafim; Luiz Henrique Martins Castro; Carolina Demarchi Munhoz; Ricardo Nitrini; Geraldo Busatto Filho; Eurípedes Constantino Miguel; Giancarlo Lucchetti; Orestes Forlenza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-06-25       Impact factor: 5.270

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.